HomeNewsBusinessCompaniesTop life insurers raise provisions as COVID-19 claims pinch hard
Trending Topics

Top life insurers raise provisions as COVID-19 claims pinch hard

ICICI Prudential Life has set aside Rs 498 crore for COVID-19 claims while HDFC Life is setting aside excess mortality reserve of Rs 700 crore. Claims had increased manifold in the June quarter

July 21, 2021 / 11:47 IST
Story continues below Advertisement

The second wave of COVID-19 and the looming threat of the third wave has severely hit large private life insurers, prompting them to shore up their provisions.

The two largest private insurers ICICI Prudential Life Insurance and HDFC Life Insurance have set aside additional provisions for COVID-19 claims.

Story continues below Advertisement

HDFC Life Insurance has set aside an excess mortality reserve of Rs 700 crore created at the balance sheet for potential adverse mortality. This reserve is over and above the policy level liabilities calculated based on the applicable IRDAI regulations. This was in addition of Rs 165 crore of the provisions.

The company's solvency position remained at 203 percent in Q1 against the statutory minimum requirement of 150 percent.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show